cholic acid has been researched along with Liver Cirrhosis, Biliary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corrigan, M; Hegade, VS; Hirschfield, GM; Holmes, E; Jones, DE; Kendrick, S; Marchesi, JR; McDonald, JAK; Pechlivanis, A; Rees, D; Taylor-Robinson, SD | 1 |
| Desai, MS; Eblimit, Z; Karpen, SJ; Kosters, A; Moore, DD; Penny, DJ; Thevananther, S | 1 |
| Chen, Y; Fickert, P; Gassler, N; Guldiken, N; Haybaeck, J; Jeon, MK; Mohammed, HH; Pollheimer, MJ; Spurny, M; Strnad, P; Trautwein, C | 1 |
| Bhatti, S; Güldütuna, S; Hübner, K; Leuschner, M; Leuschner, U; Nickel, A; Wunderlich, N | 1 |
| Chrétien, Y; Paumgartner, G; Poupon, R; Poupon, RE | 1 |
| Aldini, R; Bazzoli, F; Cipolla, A; Festi, D; Mazzella, G; Parini, P; Polimeni, C; Roda, A; Tonelli, D; Villanova, N | 1 |
| Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
| Azer, SA; Byth, K; Coverdale, SA; Farrell, GC; Stacey, NH | 1 |
| Bonner, GF; Boyer, JL; Carithers, RL; Combes, B; Garcia-Tsao, G; Hofmann, AF; Luketic, VA; Maddrey, WC; Munoz, S; Peters, MG; Risser, R; Rossi, SS; Shiffman, ML; White, H; Zetterman, RK | 1 |
4 trial(s) available for cholic acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
Topics: Bile Acids and Salts; Cholic Acid; Cholic Acids; Deoxycholic Acid; Feces; Female; Glutamate Dehydrogenase; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Ursodeoxycholic Acid | 1993 |
Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Ursodeoxycholic Acid | 1993 |
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestasis; Cholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate | 1996 |
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Topics: Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Chromatography, Gas; Chromatography, High Pressure Liquid; Deoxycholic Acid; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Regression Analysis; Reproducibility of Results; Time Factors; Ursodeoxycholic Acid | 1999 |
5 other study(ies) available for cholic acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Carrier Proteins; Case-Control Studies; Chenodeoxycholic Acid; Cholic Acid; Chromatography, Liquid; Feces; Female; Humans; Liver Cirrhosis, Biliary; Male; Membrane Glycoproteins; Methylamines; Middle Aged; Phosphoric Diester Hydrolases; Pruritus; RNA, Ribosomal, 16S; Tandem Mass Spectrometry; Thiazepines | 2019 |
Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.
Topics: Adrenergic beta-Agonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biomarkers; Cardiomyopathies; Cholestasis; Cholic Acid; Disease Models, Animal; Drug Resistance; Liver; Liver Cirrhosis, Biliary; Male; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Recovery of Function; Signal Transduction; Time Factors; Ventricular Function, Left | 2015 |
Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Topics: Animals; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cholangitis, Sclerosing; Cholestasis, Extrahepatic; Cholic Acid; Choline Deficiency; Common Bile Duct; Disease Models, Animal; Epithelial Cells; Ethionine; Keratin-19; Ligation; Liver; Liver Cirrhosis, Biliary; Liver Regeneration; Male; Mice, Knockout; Phenotype; Pyridines; Signal Transduction; Stem Cells; Time Factors | 2015 |
Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
Topics: Adult; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid | 1993 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |